Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Jones

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Psychopharmacology|September 3, 2008
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040Eric Southam, Jackie Cilia, Jane E Gartlon, et al.
Journal of Proteome Research|April 30, 2009
Antipsychotic treatment alters protein expression associated with presynaptic function and nervous system development in rat frontal cortexDan Ma, Man K Chan, Helen E Lockstone, et al.
European Journal of Pharmacology|November 3, 2009
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristicsLee A Dawson, Christopher J Langmead, Adeshola Dada, et al.
Brain Research|April 17, 2007
Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophreniaMelanie J Robbins, Kathryn R Starr, Andy Honey, et al.
Psychopharmacology|June 19, 2004
Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in ratsJane Gartlon, Philip Szekeres, Mark Pullen, et al.
Brain : a Journal of Neurology|September 11, 2019
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S miceRenzo Mancuso, Gemma Fryatt, Madeleine Cleal, et al.
The Journal of Chemical Physics|October 17, 2015
Electronic excitation of furfural as probed by high-resolution vacuum ultraviolet spectroscopy, electron energy loss spectroscopy, and ab initio calculationsF Ferreira da Silva, E Lange, P Limão-Vieira, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Tackling gaps in developing life-changing treatments for dementiaRui Mauricio, Caroline Benn, John Davis, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
Studies towards the identification of a new generation of atypical antipsychotic agentsVincenzo Garzya, Ian T Forbes, Andrew D Gribble, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical modelsAndrew D Medhurst, Alan R Atkins, Isabel J Beresford, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Psychopharmacology|September 3, 2008
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040Eric Southam, Jackie Cilia, Jane E Gartlon, et al.
Journal of Proteome Research|April 30, 2009
Antipsychotic treatment alters protein expression associated with presynaptic function and nervous system development in rat frontal cortexDan Ma, Man K Chan, Helen E Lockstone, et al.
European Journal of Pharmacology|November 3, 2009
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristicsLee A Dawson, Christopher J Langmead, Adeshola Dada, et al.
Brain Research|April 17, 2007
Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophreniaMelanie J Robbins, Kathryn R Starr, Andy Honey, et al.
Psychopharmacology|June 19, 2004
Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in ratsJane Gartlon, Philip Szekeres, Mark Pullen, et al.
Brain : a Journal of Neurology|September 11, 2019
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S miceRenzo Mancuso, Gemma Fryatt, Madeleine Cleal, et al.
The Journal of Chemical Physics|October 17, 2015
Electronic excitation of furfural as probed by high-resolution vacuum ultraviolet spectroscopy, electron energy loss spectroscopy, and ab initio calculationsF Ferreira da Silva, E Lange, P Limão-Vieira, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Tackling gaps in developing life-changing treatments for dementiaRui Mauricio, Caroline Benn, John Davis, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2006
Studies towards the identification of a new generation of atypical antipsychotic agentsVincenzo Garzya, Ian T Forbes, Andrew D Gribble, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical modelsAndrew D Medhurst, Alan R Atkins, Isabel J Beresford, et al.
Pageof 13